{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:38:13Z","timestamp":1790699893072,"version":"4.1.0"},"reference-count":75,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["J3-2356 and P3-0343."],"award-info":[{"award-number":["J3-2356 and P3-0343."]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Hypercholesterolemia is a major cause of atherosclerosis development and premature cardiovascular disease (CVD). It leads to inflammation, which further accelerates atherosclerosis progression. Familial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by elevated serum LDL-c from birth, due to a disease-causing variant in one of the causative genes (LDLR, APOB, PCSK9). In polygenic hypercholesterolemia (PH), the disease-causing genetic variant is absent; it is likely the cumulative result of multiple single nucleotide polymorphisms in LDL metabolism-related genes and other factors, such as lifestyle and environment. In high risk groups, such as patients with FH, an effective primary prevention of CVD must begin in childhood. High-sensitivity C-reactive protein (hsCRP) and carotid intima media thickness (cIMT) are two potential minimally invasive correlates of inflammation and subclinical atherosclerosis progression. hsCRP and cIMT have been shown to be significantly increased in patients with FH and PH relative to healthy controls, with some studies yielding conflicting results. In this review, we aim to summarize current knowledge and recent findings regarding the applicability of hsCRP and cIMT as markers of low-grade inflammation and subclinical atherosclerosis, focusing especially on children and adolescents with hypercholesterolemia.<\/jats:p>","DOI":"10.3390\/molecules25215118","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:37Z","timestamp":1604534437000},"page":"5118","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["High-Sensitivity C-Reactive Protein and Carotid Intima Media Thickness as Markers of Subclinical Inflammation and Atherosclerosis in Pediatric Patients with Hypercholesterolemia"],"prefix":"10.3390","volume":"25","author":[{"given":"Lana","family":"Blinc","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1143-2880","authenticated-orcid":false,"given":"Matej","family":"Mlinaric","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital, University Medical Center Ljubljana, Bohoriceva ulica 20, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia"},{"name":"University Children\u2019s Hospital, University Medical Center Ljubljana, Bohoriceva ulica 20, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5246-9869","authenticated-orcid":false,"given":"Urh","family":"Groselj","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia"},{"name":"University Children\u2019s Hospital, University Medical Center Ljubljana, Bohoriceva ulica 20, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"ref_1","first-page":"241","article-title":"Worldwide burden of LDL cholesterol: Implications in cardiovascular disease","volume":"20230","author":"Mattiuzzi","year":"2019","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.290.17.2277","article-title":"Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: The Cardiovascular Risk in Young Finns Study","volume":"290","author":"Raitakari","year":"2003","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jacc.2019.03.529","article-title":"Associations of Blood Pressure and Cholesterol Levels during Young Adulthood with Later Cardiovascular Events","volume":"74","author":"Zhang","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: A case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease: Consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2018.06.858","article-title":"Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review","volume":"277","author":"Groselj","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41419-020-02985-x","article-title":"NLRP3 inflammasome in endothelial dysfunction","volume":"11","author":"Bai","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolemia in children and adolescents: Gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2013.01.025","article-title":"Carotid intima-media thickness for cardiovascular risk assessment: Systematic review and meta-analysis","volume":"228","author":"Sijbrands","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","article-title":"Predicition of Clinical Cardiovascular Events with Carotid Intima-media Thickness","volume":"115","author":"Lorenz","year":"2007","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"561428","DOI":"10.1155\/2014\/561428","article-title":"C-Reactive Protein in Human Atherogenesis: Facts and Fiction","volume":"2014","author":"Zimmermann","year":"2014","journal-title":"Med. Inflamm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.medici.2015.12.001","article-title":"Clinical relevance of high sensitivity C-reactive protein in cardiology","volume":"52","year":"2016","journal-title":"Medicina"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12944-017-0470-1","article-title":"Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: A case control study","volume":"16","author":"Rahman","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2169\/internalmedicine.50.4297","article-title":"Examination of adhesion molecules, homocysteine and hs-CRP in patients with polygenic hypercholesterolemia and isolated hypertriglyceridemia","volume":"50","author":"Calan","year":"2011","journal-title":"Int. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.atherosclerosis.2020.03.022","article-title":"UCC-SMART study group. The relation between healthy lifestlyle changes and decrease in systemic inflammation in patients with stable cardiovascular disease","volume":"301","author":"Ridker","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/CIRCULATIONAHA.116.025158","article-title":"Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)","volume":"136","author":"Braamskamp","year":"2017","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11883-020-00876-2","article-title":"Preventive Cardiology and Risk Assessment: Beyond LDL","volume":"22","author":"Goyal","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of Familial Hypercholesterolemia among the General Population and Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11886-017-0848-8","article-title":"Genetic Architecture of Familial Hypercholesterolaemia","volume":"19","author":"Sharifi","year":"2017","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phrs.2019.03.016","article-title":"A review of gene- and cell-based therapies for familial hypercholesterolemia","volume":"143","author":"Hajighasemi","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.27227","article-title":"Autosomal Recessive Hypercholesterolemia: A Mild Phenotype of Familial Hypercholesterolemia: Insight from the Kinetic Study using Stable Isotope and Animal Studies","volume":"22","author":"Tada","year":"2014","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.atherosclerosis.2018.06.006","article-title":"Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia","volume":"277","author":"Futema","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1161\/ATVBAHA.116.308027","article-title":"Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically","volume":"36","author":"Wang","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11883-014-0482-5","article-title":"Familial Hypercholesterolemia\u2014Epidemiology, Diagnosis, and Screening","volume":"17","author":"Singh","year":"2015","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia. Homozygous familial hypercholesterolaemia: New insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MOL.0000000000000482","article-title":"Polygenic influences on dyslipidemias","volume":"29","author":"Dron","year":"2018","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1194\/jlr.S074039","article-title":"Knowns and unknowns in the care of pediatric hypercholesterolemia","volume":"58","author":"Martin","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_29","first-page":"CD006401","article-title":"Statins for children with familial hypercholesterolemia","volume":"7","author":"Vuorio","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacc.2013.05.016","article-title":"High-sensitivity C-reactive protein and cardiovascular disease: A resolute belief or an elusive link?","volume":"62","author":"Yousuf","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_32","first-page":"e168","article-title":"C-Reactive Protein-Induced In Vitro Vasorelaxation Is an Artefact Caused by the Presence of Sodium Azide in Commercial Preparations","volume":"24","author":"Taylor","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/01.ATV.0000164623.41250.28","article-title":"C-Reactive Protein-Induced In Vitro Endothelial Cell Activation Is an Artefact Caused by Azide and Lipopolysaccharide","volume":"25","author":"Taylor","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/cvr\/cvp249","article-title":"C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction","volume":"84","author":"Devaraj","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.RES.0000163015.67711.AB","article-title":"Activation of inflammation and coagulation after infusion of C-reactive protein in humans","volume":"96","author":"Bisoendial","year":"2005","journal-title":"Circ. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1161\/res.97.7.e71","article-title":"In response to van den Berg et al.: On the direct actions of CRP in humans","volume":"97","author":"Bisoendial","year":"2005","journal-title":"Circ. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1016\/j.ijcard.2013.07.113","article-title":"High-sensitivity C-reactive protein and atherosclerotic disease: From improved risk prediction to risk-guided therapy","volume":"168","author":"Koenig","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.CIR.97.20.2007","article-title":"C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Emerging Risk Factors Collaboration, Kaptoge, S., Di Angelantonio, E., Lowe, G., Pepys, M.B., Thompson, S.G., Collins, R., and Danesh, J. (2010). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet, 375, 132\u2013140.","DOI":"10.1016\/S0140-6736(09)61717-7"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative Group, Emberson, J., Bennett, D., Link, E., Parish, S., Danesh, J., Armitage, J., and Collins, R. (2011). C-reactive protein concentration and the vascular benefits of statin therapy: An analysis of 20,536 patients in the Heart Protection Study. Lancet, 377, 469\u2013476.","DOI":"10.1016\/S0140-6736(10)62174-5"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ije\/dyn217","article-title":"Critical appraisal of CRP measurement for the prediction of coronary heart disease events: New data and systematic review of 31 prospective cohorts","volume":"38","author":"Shah","year":"2009","journal-title":"Int. J. Epidemiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S0266462309990870","article-title":"Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: A health technology assessment report","volume":"26","author":"Schwarzer","year":"2010","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0021-9150(02)00280-0","article-title":"Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy","volume":"165","author":"Trip","year":"2002","journal-title":"Atherosclerosis"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2014.05.917","article-title":"Markers of atherosclerotic development in children with familial hypercholesterolemia: A literature review","volume":"235","author":"Narverud","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2015.09.014","article-title":"Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia","volume":"243","author":"Narverud","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2362.2006.01613.x","article-title":"Increased inflammatory markers in children with familial hypercholesterolaemia","volume":"36","author":"Ueland","year":"2006","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1651-2227.2007.00377.x","article-title":"High-sensitivity C-reactive protein in children at risk for coronary artery disease","volume":"96","author":"Guran","year":"2007","journal-title":"Acta Paediatr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1042\/CS20150235","article-title":"Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric age","volume":"129","author":"Martino","year":"2015","journal-title":"Clin. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2016.11.031","article-title":"Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia","volume":"256","author":"Christensen","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000343145","article-title":"Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011","volume":"34","author":"Touboul","year":"2012","journal-title":"Cerebrovasc. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.CIR.74.6.1399","article-title":"Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging","volume":"74","author":"Pignoli","year":"1986","journal-title":"Circulation"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/2047487315625543","article-title":"Normative values for carotid intima media thickness and its progression: Are they transferrable outside of their cohort of origin?","volume":"23","author":"Liao","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(12)60441-3","article-title":"Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): A meta-analysis of individual participant data","volume":"379","author":"Lorenz","year":"2012","journal-title":"Lancet"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1093\/eurheartj\/ehs380","article-title":"Reference Values for Arterial Measurements Collaboration. Reference intervals for common carotid intma-media thickness measured with echotracking: Relation with risk factors","volume":"34","author":"Engelen","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1089\/met.2017.0149","article-title":"Association Between Carotid Intima Media Thickness, Age, and Cardiovascular Risk Factors in Children and Adolescents","volume":"16","author":"Gooty","year":"2018","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_59","first-page":"327","article-title":"Assessment of Intima-media Thickness in Healthy Children Aged 1 to 15 Years","volume":"106","author":"Baroncini","year":"2016","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1590\/1984-0462\/;2019;37;4;00010","article-title":"Intima-Media Thickness of the Carotid Arteries is Affected by Pubertal Maturation in Healthy Adolescents","volume":"37","author":"Zanini","year":"2019","journal-title":"Rev. Paul. Pediatr."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2459\/JCM.0000000000000295","article-title":"Carotid artery intima-media thickness and stiffness index \u03b2 changes in normal children: Role of age, height and sex","volume":"18","author":"Carerj","year":"2017","journal-title":"J. Cardiovasc. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4982676","DOI":"10.1155\/2016\/4982676","article-title":"Growing-Related Changes in Arterial Properties of Healthy Childre, Adolescents and Adults Nonexposed to Cardiovascular Risk Factors: Analysis of Gender-Related Differences","volume":"2016","author":"Curcio","year":"2016","journal-title":"Int. J. Hypertens."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3906\/sag-1304-22","article-title":"Relation of age and sex with carotid intima media thickness in healthy children","volume":"44","author":"Yilmaz","year":"2014","journal-title":"Turk. J. Med. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/HYPERTENSIONAHA.109.192639","article-title":"Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents: Recommendations for Standard Assessment for Clinical Research: A Scientific Statement from the American Heart Association","volume":"54","author":"Urbina","year":"2009","journal-title":"Hypertension"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.atherosclerosis.2014.12.029","article-title":"Intima media thickness measurement in children: A statement from the Association for European Paediatric Cardiology (AEPC) Working Group on Cardiovascular Prevention endorsed by the Association for European Paediatric Cardiology","volume":"238","author":"Fritsch","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1161\/STROKEAHA.111.625186","article-title":"Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis","volume":"42","author":"Polak","year":"2011","journal-title":"Stroke"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Lorenz, M.W., Gao, L., Ziegelbauer, K., Norata, G.D., Empana, J.P., Schmidtmann, I., Lin, H.-J., McLachlan, S., Bokemark, L., and Ronkainen, K. (2018). Predictive value for cardiovascular events of common carotid intima media thicknes and its rate of change in individuals at high cardiovascular risk\u2014Results from the PROG-IMT collaboration. PLoS ONE, 13, reprinted in PLoS ONE 2018, 13, e0204633.","DOI":"10.1371\/journal.pone.0204633"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/CIRCULATIONAHA.120.046361","article-title":"Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100,667 Patients","volume":"142","author":"Willeit","year":"2020","journal-title":"Circulation"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.292.3.331","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia: A randomized controlled trial","volume":"292","author":"Wiegman","year":"2004","journal-title":"J. Am. Med. Assoc."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jama.2014.8892","article-title":"Ten-Year Follow-up After Initiation of Statin Therapy in Children with Familial Hypercholesterolemia","volume":"312","author":"Kusters","year":"2014","journal-title":"J. Am. Med. Assoc."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.2174\/1381612824666181010145807","article-title":"Familial Hypercholesterolemia in Children and Adolescents: Diagnosis and Treatment","volume":"24","author":"Maliachova","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.atherosclerosis.2017.05.015","article-title":"Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia","volume":"263","author":"Sharifi","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11886-019-1130-z","article-title":"Polygenic Hypercholesterolemia and Cardiovascular Disease Risk","volume":"21","author":"Sharifi","year":"2019","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/heartjnl-2015-308845","article-title":"Cardiovascular risk stratification in familial hypercholesterolemia","volume":"102","author":"Sharifi","year":"2016","journal-title":"Heart"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"597768","DOI":"10.3389\/fcvm.2020.597768","article-title":"Carotid Intima-Media Thickness in Healthy Children and Adolescents: Normative Data and Systematic Literature Review","volume":"7","author":"Plesnik","year":"2020","journal-title":"Front. Cardiovasc. Med."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/21\/5118\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:28:57Z","timestamp":1760178537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/21\/5118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":75,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["molecules25215118"],"URL":"https:\/\/doi.org\/10.3390\/molecules25215118","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]}}}